Anti-infection Therapy Based on mNGS Etiological Diagnosis and Infection After Liver Transplantation

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2027

Conditions

Infection

Interventions

DIAGNOSTIC_TEST

mNGS

metagenomics next generation sequencing

Trial Locations (1)

Shenzhen Third People's Hospital, Shenzhen

All Listed Sponsors

lead

Shenzhen Third People's Hospital

OTHER

NCT06212115 - Anti-infection Therapy Based on mNGS Etiological Diagnosis and Infection After Liver Transplantation | Biotech Hunter | Biotech Hunter